🇺🇸 FDA
Patent

US 10155020

Compositions and methods for treating hepatitis B

granted A61KA61K38/00A61K38/04

Quick answer

US patent 10155020 (Compositions and methods for treating hepatitis B) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K38/04, A61P, A61P31/20